ACE and stage 5 chronic kidney disease: Previously reported patients who received immunosuppressive therapy or angiotensin-converting enzyme inhibitors(ACEI)/angiotensin receptor blockers(ARBs) showed poor response to therapy and progressed to end-stage renal disease or deteriorated renal function.[12,13] Currently no recommendations or guidelines are available for the treatment of MN with crescents.